BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Ovarian cancer

1. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [